Real-World Experience with Novel VMAT2 Inhibitors

被引：0
|
作者：
Niemann, Nicki [1 ]
Jankovic, Joseph [1 ]
机构：
[1] Baylor Coll Med, Parkinsons Dis Ctr & Movement Disorders Clin, Dept Neurol, Houston, TX 77030 USA
来源：
NEUROTHERAPEUTICS | 2018年 / 15卷 / 04期
关键词：
TETRABENAZINE;
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
59
引用
收藏
页码：1190 / 1191
页数：2
相关论文
共 50 条
  • [1] Real-World Experience With VMAT2 Inhibitors
    Niemann, Nicki
    Jankovic, Joseph
    CLINICAL NEUROPHARMACOLOGY, 2019, 42 (02) : 37 - 41
  • [2] Real-world experience with VMAT2 inhibitors in Tourette syndrome
    Karim Makhoul
    Joseph Jankovic
    Journal of Neurology, 2023, 270 : 4518 - 4522
  • [3] Real-world experience with VMAT2 inhibitors in Tourette syndrome
    Makhoul, Karim
    Jankovic, Joseph
    JOURNAL OF NEUROLOGY, 2023, 270 (09) : 4518 - 4522
  • [4] Real-World Use and Impact of VMAT2 Inhibitors in Patients with Tardive Dyskinesia
    Lundt, L.
    Franey, E.
    Yonan, C.
    MOVEMENT DISORDERS, 2020, 35 : S40 - S40
  • [5] VMAT2 Inhibitors in Neuropsychiatric Disorders
    Tarakad, Arjun
    Jimenez-Shahed, Joohi
    CNS DRUGS, 2018, 32 (12) : 1131 - 1144
  • [6] VMAT2 Inhibitors in Neuropsychiatric Disorders
    Arjun Tarakad
    Joohi Jimenez-Shahed
    CNS Drugs, 2018, 32 : 1131 - 1144
  • [7] VMAT2 inhibitors for the treatment of tardive dyskinesia
    Scorr, Laura M.
    Factor, Stewart A.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2018, 389 : 43 - 47
  • [8] VMAT2 Inhibitors for the Treatment of Tardive Dyskinesia
    Warren, Barbara
    Vanderhoef, Dawn
    Johnson, Jessica
    ISSUES IN MENTAL HEALTH NURSING, 2022, 43 (01) : 22 - 31
  • [9] New generation VMAT2 inhibitors induced parkinsonism
    Vasireddy, Rani Priyanka
    Sokola, Brent
    Guduru, Zain
    CLINICAL PARKINSONISM & RELATED DISORDERS, 2020, 3
  • [10] VMAT2 inhibitors for the treatment of hyperkinetic movement disorders
    Koch, Jessa
    Shi, Wei-Xing
    Dashtipour, Khashayar
    PHARMACOLOGY & THERAPEUTICS, 2020, 212
12345